Talk:Joseph Jimenez

Latest comment: 1 year ago by 3mi1y in topic Requesting update to Career section

Editing article for NPOV

edit

Hi, I'm Katya – a social media manager at Novartis. I'm aware of WP:COI and thus would like to raise to the community some portions of this article that I think could be improved.

It looks like Section 3.1 was simply copied and pasted in its entirety from the article on Novartis.

I'm not sure if this section should be here, for a number of reasons. The duplication seems to be redundant (especially as there's an extensive record of this information on the main Novartis article). Also, most of these controversies happened before Joseph Jimenez became CEO in 2010. Some of them even happened before he joined Novartis in 2007.

The last part of this section (3.1.6) has actually been cut from the main Novartis article. The court case is ongoing, so there’s no solid story yet. In the interests of NPOV, wouldn’t it be better to wait until the case is settled one way or the other before writing about it?

Finally, the Conflicts and Criticisms section is much, much larger than the rest of the article. Doesn't this constitute Undue Weight?

For the reasons listed above I’d recommend to remove the section 3.1. Please let me know what you think. Katya Reck (talk) 14:57, 6 December 2013 (UTC)Reply

Hello. OMG, the section 3.1 is so wrong here. You are absolutely right, I deleted it. Regards --KurtR (talk) 22:30, 26 December 2013 (UTC)Reply

Request edit: Jimenez stepped down from the Board of Directors of startup uBiome

edit

Can you please update the "Novartis" section in the article to add, "Jimenez stepped down from the Board of Directors of startup uBiome in April 2019 to run his own venture fund."[1][2][3][4] Naomi at Ruder Finn (talk) 19:36, 17 June 2019 (UTC)Reply

References

  1. ^ Ramsey, Lydia (May 17, 2019). "Dispensed: How health insurance startups fared at the start of 2019, Impossible Foods' big burger change, and a look at uBiome's board".
  2. ^ "UBiome's independent directors are dropping the health care start-up following an FBI raid, and now there's just 1 left". May 15, 2019.
  3. ^ "UBiome's Independent Directors are Ditching the Healthcare Startup Following an FBI Raid". May 15, 2019.
  4. ^ Ramsey, Lydia (May 15, 2019). "uBiome's independent directors are ditching the healthcare startup following an FBI raid, and now there's only 1 left".
@Naomi at Ruder Finn:   DoneMJLTalk 20:11, 17 June 2019 (UTC)Reply

Date of birth is needed.--109.252.91.11 (talk) 05:14, 8 November 2020 (UTC)Reply

Add information about Joseph Jimenez's Board positions

edit

Joseph Jimenez serves on the boards of multiple companies and it would be great to create a new section called 'Board positions' after the 'Novartis' section. The information about his board positions is provided below, along with citations for each.

Can you please move the sentence "Jimenez joined the board of directors at General Motors on June 9, 2015[1]." from the 'Novartis' section to the beginning of the 'Board positions' section?

Can you please add the below to the 'Board positions' section after the General Motors sentence:

Jimenez also has served on the Board of Directors of Procter & Gamble since 2018, where he is lead independent director[2]. He also serves as Chairman of Century Therapeutics, an iPSC derived allogeneic cell therapy company, and is on the Board of Graphite Bio, a gene therapy company[3][4].

Isabelle at Ruder Finn (talk) 17:15, 2 August 2022 (UTC)Reply

  Not done: Denied due to a lack of independent and reliable sourcing, pursuant to WP:RS. Also, it is unnecessary to create a new section for his board positions. That can go into the article's Career section. Quetstar (talk) 17:51, 2 August 2022 (UTC)Reply
Thank you for your feedback. I have provided alternative references from reputable third party sources for each of the Board position entries below. Please let me know if this works for you and can be incorporated into the article. Ok to have it as part of the Career section as you recommended.
Jimenez joined the board of directors at General Motors on June 9, 2015.
Source: https://www.fiercepharma.com/pharma/p-g-investors-wish-for-ceo-joe-jimenez-as-outgoing-novartis-chief-joins-board
Jimenez also has served on the Board of Directors of Procter & Gamble since 2018, where he is lead independent director.
Source: https://www.fiercepharma.com/pharma/p-g-investors-wish-for-ceo-joe-jimenez-as-outgoing-novartis-chief-joins-board
He also serves as Chairman of Century Therapeutics, an iPSC derived allogeneic cell therapy company, and is on the Board of Graphite Bio, a gene therapy company.
Source: https://www.biospace.com/article/releases/century-therapeutics-expands-board-of-directors-with-key-appointments/
Source: https://www.bloomberg.com/profile/company/1830598D:US?sref=5GnwNQsL Isabelle at Ruder Finn (talk) 13:43, 3 August 2022 (UTC)Reply

Requesting update to Career section

edit

Per the feedback provided above by Quetstar[1], I have revised the request and since I haven't heard back from Quetstar for a couple of weeks, I would like to re-submit this request to the general Talk page in the hopes that some other editor will review and publish these edits.

Can you please add the following information to the Careers section:

Jimenez joined the board of directors at General Motors on June 9, 2015[2].

Jimenez also has served on the Board of Directors of Procter & Gamble since 2018, where he is lead independent director[3].

He also serves as Chairman of Century Therapeutics, an iPSC derived allogeneic cell therapy company, and is on the Board of Graphite Bio, a gene therapy company[4][5].

(You can reopen a request by removing the |D or |P from the end of the {{edit COI}}. We're unlikely to see it if it's still marked as closed, because it won't show up on the list of still-open ones.)
  Done mi1yT·C 20:21, 21 November 2022 (UTC)Reply

Isabelle at Ruder Finn (talk) 18:03, 19 August 2022 (UTC)Reply